Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Lin Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-6756-1683; OpenAlex author ID A5110296830. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
20
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 2 papers · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 5

  1. Efficacy and safety of triplet regimen capecitabine, oxaliplatin, and irinotecan (XELOXIRI) as first-line chemotherapy for advanced pancreatic cancer. Last author DOI 10.1186/s12885-025-13799-5↗
  2. Survival benefits of radiotherapy in locally advanced unresectable and metastatic pancreatic cancer: a single-institution cohort and SEER database analysis. Last author DOI 10.3389/fonc.2024.1473251↗
  3. Zinc chelator TPEN induces pancreatic cancer cell death through causing oxidative stress and inhibiting cell autophagy. Co-author DOI 10.1002/jcp.28670↗
  4. Successful Secondary Engraftment of Pancreatic Ductal Adenocarcinoma and Cholangiocarcinoma Patient-Derived Xenografts After Previous Failed Primary Engraftmen… First author DOI 10.1016/j.tranon.2018.09.008↗
  5. Inactivation of Brca2 promotes Trp53-associated but inhibits KrasG12D-dependent pancreatic cancer development in mice. Co-author DOI 10.1053/j.gastro.2010.12.039↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Biyang Cao · 2 shared papers, 2024–2025 · strength 0.50
  2. Letian Zhang · 2 shared papers, 2024–2025 · strength 0.50
  3. Jing Wang · 1 shared paper, 2024 · strength 0.28
  4. Wen Zhang · 1 shared paper, 2025 · strength 0.22
  5. Wenwei Yang · 1 shared paper, 2025 · strength 0.22
  6. Xiaoting Ma · 1 shared paper, 2025 · strength 0.22
  7. Kai Ou · 1 shared paper, 2025 · strength 0.22
  8. Matthew C. Hernandez · 1 shared paper, 2019 · strength 0.10
  9. John R. Bergquist · 1 shared paper, 2019 · strength 0.10
  10. Jennifer L. Leiting · 1 shared paper, 2019 · strength 0.10
  11. Rondell Patrell Graham · 1 shared paper, 2019 · strength 0.10
  12. Mark Joseph Truty · 1 shared paper, 2019 · strength 0.10
  13. Zhen Yu · 1 shared paper, 2019 · strength 0.10
  14. Chun‐Bo Teng · 1 shared paper, 2019 · strength 0.10
  15. Ze Yu · 1 shared paper, 2019 · strength 0.10
  16. Yuzhe Nie · 1 shared paper, 2019 · strength 0.10
  17. Thomas C. Smyrk · 1 shared paper, 2011 · strength 0.02
  18. Matthew Rowley · 1 shared paper, 2011 · strength 0.02
  19. Michael H. Muders · 1 shared paper, 2011 · strength 0.02
  20. Fergus Joseph Couch · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.